1. Home
  2. AMZE vs BMRA Comparison

AMZE vs BMRA Comparison

Compare AMZE & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amaze Holdings Inc.

AMZE

Amaze Holdings Inc.

HOLD

Current Price

$0.33

Market Cap

14.3M

ML Signal

HOLD

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$1.90

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMZE
BMRA
Founded
2019
1971
Country
United States
United States
Employees
4
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3M
6.3M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
AMZE
BMRA
Price
$0.33
$1.90
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
991.8K
8.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,311,000.00
Revenue This Year
$6,741.66
N/A
Revenue Next Year
$100.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.40
52 Week High
$11.76
$4.60

Technical Indicators

Market Signals
Indicator
AMZE
BMRA
Relative Strength Index (RSI) 43.82 28.66
Support Level $0.30 N/A
Resistance Level $0.41 $2.89
Average True Range (ATR) 0.04 0.12
MACD -0.00 -0.01
Stochastic Oscillator 34.59 9.09

Price Performance

Historical Comparison
AMZE
BMRA

About AMZE Amaze Holdings Inc.

Amaze Holdings Inc is a software company dedicated to empowering creators by providing comprehensive software solutions and services that facilitate e-commerce, social commerce, integrated commerce selling experiences, and the distribution of a premium wine brand. The group offers an end-to-end, creator-powered commerce platform offering tools for seamless product creation, modern e-commerce solutions, and scalable managed services.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: